Patent Issued for Compositions and methods for plasmapheresis (USPTO 12005172).

Lyfspn Inc. has been issued a patent for compositions and methods for plasmapheresis. The patent describes a method of providing plasmapheresis to an individual in order to improve their health status. The method involves measuring various factors such as strength, balance, mental status, and walking ability before and after the administration of plasmapheresis, and comparing the pre- and post-treatment health status to determine improvement. The patent also discusses using plasmapheresis to treat conditions associated with aging and modulating the expression of cell surface markers on white blood cells. The method can be repeated until a specific value or change is achieved. [Extracted from the article]